Paolo Perini, Mauro Gargiulo, Roberto Silingardi, Stefano Bonardelli, Raffaello Bellosta, Gabriele Piffaretti, Stefano Michelagnoli, Mauro Ferrari, Giorgio Ubaldo Turicchia, Antonio Freyrie, Anna Fornasari, Erica Mariani, GianLuca Faggioli, Paolo Spath, Mattia Migliari, Stefano Gennai, Barbara Paro, Paolo Baggi, Luca Attisani, Matteo Pegorer, Marco Franchin, Francesca Mauri, Emiliano Chisci, Nicola Troisi, Elisa Paciaroni, Mara Fanelli
{"title":"受感染的腹主动脉内膜移植物移植的25年多中心经验。","authors":"Paolo Perini, Mauro Gargiulo, Roberto Silingardi, Stefano Bonardelli, Raffaello Bellosta, Gabriele Piffaretti, Stefano Michelagnoli, Mauro Ferrari, Giorgio Ubaldo Turicchia, Antonio Freyrie, Anna Fornasari, Erica Mariani, GianLuca Faggioli, Paolo Spath, Mattia Migliari, Stefano Gennai, Barbara Paro, Paolo Baggi, Luca Attisani, Matteo Pegorer, Marco Franchin, Francesca Mauri, Emiliano Chisci, Nicola Troisi, Elisa Paciaroni, Mara Fanelli","doi":"10.1177/00033197231206430","DOIUrl":null,"url":null,"abstract":"<p><p>We report a multicenter experience of open conversions (OC) for aortic endograft infections (AEI). We retrospectively analyzed all patients who underwent OC for AEI after endovascular aneurysm repair (EVAR), from 1997 to 2021 in 12 Italian centers. The endpoints were as follows: mortality (30-days, in-hospital), major postoperative complications. Follow-up data included: survival, aortic-related complications, infection persistence or reoccurrence. Fifty-eight patients (mean age: 73.8 ± 6.6 years) were included. Median time from EVAR to OC was 14 months (interquartile range 7-45). Thirty-five patients (60.3%) were symptomatic at presentation. Aortic reconstruction was anatomic in 32 patients (55.2%), extra-anatomic in 26 (44.8%). Thirty-day mortality was 31% (18/58). Six additional patients died after 30 days during the same hospitalization (in-hospital mortality: 41.4%). Most common post-operative complications included respiratory failure (38.6%) and renal insufficiency (35.1%). During 28.1 ± 4 months follow-up, 4 aneurysm-related deaths were recorded. Infection re-occurred in 29.4% of the patients. Estimated survival was 50% at 1 year, and 30% at 5 years, and was significantly lower for patients who underwent extra-anatomic reconstructions (37 <i>vs</i> 61% at 1 year, 16 <i>vs</i> 45% at 5 years; log-rank <i>P</i> = .021). OC for AEI is associated with high early mortality. The poor mid-term survival is influenced by aortic complications and infection re-occurrence.</p>","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"85-93"},"PeriodicalIF":2.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Twenty-Five Year Multicentre Experience of Explantation of Infected Abdominal Aortic Endografts.\",\"authors\":\"Paolo Perini, Mauro Gargiulo, Roberto Silingardi, Stefano Bonardelli, Raffaello Bellosta, Gabriele Piffaretti, Stefano Michelagnoli, Mauro Ferrari, Giorgio Ubaldo Turicchia, Antonio Freyrie, Anna Fornasari, Erica Mariani, GianLuca Faggioli, Paolo Spath, Mattia Migliari, Stefano Gennai, Barbara Paro, Paolo Baggi, Luca Attisani, Matteo Pegorer, Marco Franchin, Francesca Mauri, Emiliano Chisci, Nicola Troisi, Elisa Paciaroni, Mara Fanelli\",\"doi\":\"10.1177/00033197231206430\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We report a multicenter experience of open conversions (OC) for aortic endograft infections (AEI). We retrospectively analyzed all patients who underwent OC for AEI after endovascular aneurysm repair (EVAR), from 1997 to 2021 in 12 Italian centers. The endpoints were as follows: mortality (30-days, in-hospital), major postoperative complications. Follow-up data included: survival, aortic-related complications, infection persistence or reoccurrence. Fifty-eight patients (mean age: 73.8 ± 6.6 years) were included. Median time from EVAR to OC was 14 months (interquartile range 7-45). Thirty-five patients (60.3%) were symptomatic at presentation. Aortic reconstruction was anatomic in 32 patients (55.2%), extra-anatomic in 26 (44.8%). Thirty-day mortality was 31% (18/58). Six additional patients died after 30 days during the same hospitalization (in-hospital mortality: 41.4%). Most common post-operative complications included respiratory failure (38.6%) and renal insufficiency (35.1%). During 28.1 ± 4 months follow-up, 4 aneurysm-related deaths were recorded. Infection re-occurred in 29.4% of the patients. Estimated survival was 50% at 1 year, and 30% at 5 years, and was significantly lower for patients who underwent extra-anatomic reconstructions (37 <i>vs</i> 61% at 1 year, 16 <i>vs</i> 45% at 5 years; log-rank <i>P</i> = .021). OC for AEI is associated with high early mortality. The poor mid-term survival is influenced by aortic complications and infection re-occurrence.</p>\",\"PeriodicalId\":8264,\"journal\":{\"name\":\"Angiology\",\"volume\":\" \",\"pages\":\"85-93\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Angiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/00033197231206430\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Angiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00033197231206430","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/11 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
我们报告了主动脉内移植物感染(AEI)开放性转化(OC)的多中心经验。我们回顾性分析了1997年至2021年在12个意大利中心接受血管内动脉瘤修复术(EVAR)后AE I OC的所有患者。终点如下:死亡率(住院30天),主要术后并发症。随访数据包括:生存率、主动脉相关并发症、感染持续性或复发。58名患者(平均年龄:73.8±6.6岁)被纳入研究。从EVAR到OC的中位时间为14个月(四分位间距7-45)。35名患者(60.3%)出现症状。32例(55.2%)患者采用解剖结构重建主动脉,26例(44.8%)患者采用超解剖结构重建。30天死亡率为31%(18/58)。在同一住院治疗的30天后,又有6名患者死亡(住院死亡率:41.4%)。最常见的术后并发症包括呼吸衰竭(38.6%)和肾功能不全(35.1%)。在28.1±4个月的随访中,记录了4例动脉瘤相关死亡。29.4%的患者再次感染。1年时估计生存率为50%,5年时估计存活率为30%,接受解剖外重建的患者的生存率明显较低(1年时为37%对61%,5年后为16%对45%;log秩P=.021)。AEI的OC与高早期死亡率相关。不良的中期生存率受到主动脉并发症和感染复发的影响。
Twenty-Five Year Multicentre Experience of Explantation of Infected Abdominal Aortic Endografts.
We report a multicenter experience of open conversions (OC) for aortic endograft infections (AEI). We retrospectively analyzed all patients who underwent OC for AEI after endovascular aneurysm repair (EVAR), from 1997 to 2021 in 12 Italian centers. The endpoints were as follows: mortality (30-days, in-hospital), major postoperative complications. Follow-up data included: survival, aortic-related complications, infection persistence or reoccurrence. Fifty-eight patients (mean age: 73.8 ± 6.6 years) were included. Median time from EVAR to OC was 14 months (interquartile range 7-45). Thirty-five patients (60.3%) were symptomatic at presentation. Aortic reconstruction was anatomic in 32 patients (55.2%), extra-anatomic in 26 (44.8%). Thirty-day mortality was 31% (18/58). Six additional patients died after 30 days during the same hospitalization (in-hospital mortality: 41.4%). Most common post-operative complications included respiratory failure (38.6%) and renal insufficiency (35.1%). During 28.1 ± 4 months follow-up, 4 aneurysm-related deaths were recorded. Infection re-occurred in 29.4% of the patients. Estimated survival was 50% at 1 year, and 30% at 5 years, and was significantly lower for patients who underwent extra-anatomic reconstructions (37 vs 61% at 1 year, 16 vs 45% at 5 years; log-rank P = .021). OC for AEI is associated with high early mortality. The poor mid-term survival is influenced by aortic complications and infection re-occurrence.
期刊介绍:
A presentation of original, peer-reviewed original articles, review and case reports relative to all phases of all vascular diseases, Angiology (ANG) offers more than a typical cardiology journal. With approximately 1000 pages per year covering diagnostic methods, therapeutic approaches, and clinical and laboratory research, ANG is among the most informative publications in the field of peripheral vascular and cardiovascular diseases. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 13 days